Losartan Potassium/Amlodipine Camsylate/Rosuvastatin Calcium

氯沙坦钾/樟脑磺酸氨氯地平/瑞舒伐他汀钙

Report date: 2026/02/03 10:08:03

Base Information

Drug NameLosartan Potassium/Amlodipine Camsylate/Rosuvastatin Calcium
Drug Alias NameAmosartan Q
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors +[4] 
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelThiazide-sensitive sodium-chloride cotransporter +[4] 
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsHyperlipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/07/14
Country/TerritorySouth Korea
CombinationsYes Losartan PotassiumAmlodipine CamsylateRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A